AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32773216 — intervention group
Group type: COMPARATOR
Intervention: Anterior–posterior connectivity in the alpha band
Number of subjects: 47
Study 35729025 — intervention group
Group type: COMPARATOR
Intervention: Ivermectin (Outpatient)
Number of subjects: 797285
Study 35729025 — intervention group
Group type: COMPARATOR
Intervention: Ivermectin (Inpatient not requiring Intensive Care)
Number of subjects: 797285
Study 35729025 — intervention group
Group type: COMPARATOR
Intervention: Ivermectin (Intensive care)
Number of subjects: 797285
Study 34663379 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine treatment
Number of subjects: 41
Study 34663379 — intervention group
Group type: EXPERIMENTAL
Intervention: XR-naltrexone treatment
Number of subjects: 41
Study 32664070 — intervention group
Group type: COMPARATOR
Intervention: Femoral nerve block (FNB)
Number of subjects: 120
Study 32664070 — intervention group
Group type: EXPERIMENTAL
Intervention: Adductor canal block (ACB)
Number of subjects: 120
Study 34382427 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR) training
Number of subjects: 137
Study 34382427 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation
Number of subjects: 137
Study 34382427 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 137
Study 33754649 — intervention group
Group type: EXPERIMENTAL
Intervention: T helper, T cytotoxic, and natural killer cell numbers
Number of subjects: 297
Study 33754649 — intervention group
Group type: EXPERIMENTAL
Intervention: B cell numbers
Number of subjects: 297
Study 33754649 — intervention group
Group type: EXPERIMENTAL
Intervention: Unclass-switched and class-switched B cells
Number of subjects: 297
Study 32219517 — intervention group
Group type: EXPERIMENTAL
Intervention: Complementary and alternative medicine (CAM) users
Number of subjects: 500
Study 32219517 — intervention group
Group type: EXPERIMENTAL
Intervention: CAM users declining conventional cancer therapy (CCT)
Number of subjects: 500
Study 32219517 — intervention group
Group type: COMPARATOR
Intervention: Non-CAM users
Number of subjects: 500
Study 34930689 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes education based on learning modality (auditory, visual, tactile)
Number of subjects: 60
Study 34930689 — intervention group
Group type: COMPARATOR
Intervention: Standard training
Number of subjects: 60
Study 33388183 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient factors
Number of subjects: 655
Study 33388183 — intervention group
Group type: EXPERIMENTAL
Intervention: Family factors
Number of subjects: 655
Study 33388183 — intervention group
Group type: EXPERIMENTAL
Intervention: Societal factors
Number of subjects: 655
Study 33361004 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast multiscale neighbor embedding methods
Number of subjects: 0
Study 34555865 — intervention group
Group type: EXPERIMENTAL
Intervention: Low FODMAP diet (LFD)
Number of subjects: 105
Study 34555865 — intervention group
Group type: COMPARATOR
Intervention: Traditional dietary advice (TDA)
Number of subjects: 105
Study 33663905 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based childbirth education (SBCE)
Number of subjects: 56
Study 33663905 — intervention group
Group type: COMPARATOR
Intervention: Routine prenatal care
Number of subjects: 56
Study 32311184 — intervention group
Group type: EXPERIMENTAL
Intervention: Buzzy® device (external cold and vibration)
Number of subjects: 60
Study 36690924 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent transcutaneous electrical stimulation (ITES)
Number of subjects: 15
Study 36690924 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous transcutaneous electrical stimulation (CTES)
Number of subjects: 15
Study 36690924 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 15
Study 33159163 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish-oil (FO) supplementation (215 mg DHA + 285 mg EPA)
Number of subjects: 360
Study 33159163 — intervention group
Group type: COMPARATOR
Intervention: Control corn-oil capsules (without n‐3 LCPs)
Number of subjects: 360
Study 33488511 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month behavioral diabetes risk-reduction intervention
Number of subjects: 0
Study 33488511 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 34738484 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral-based Transdiagnostic Sleep and Circadian Intervention for Youth (TranS-C)
Number of subjects: 14
Study 37614053 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple combination therapy (telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg)
Number of subjects: 374
Study 37614053 — intervention group
Group type: COMPARATOR
Intervention: Dual combination therapy (telmisartan 40 mg/amlodipine 5 mg)
Number of subjects: 374
Study 33787382 — intervention group
Group type: EXPERIMENTAL
Intervention: Early steroid withdrawal (ESW)
Number of subjects: 77
Study 32098484 — intervention group
Group type: EXPERIMENTAL
Intervention: Using alcohol to cope
Number of subjects: 110
Study 32098484 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressive symptoms and severity of alcohol consumption
Number of subjects: 110
Study 34519685 — intervention group
Group type: EXPERIMENTAL
Intervention: Active priming stimulation (6-Hz rTMS at 80% resting motor threshold) followed by 1-Hz rTMS
Number of subjects: 30
Study 34519685 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation followed by 1-Hz rTMS
Number of subjects: 30
Study 32485663 — intervention group
Group type: EXPERIMENTAL
Intervention: Thai dance exercise on sand surface
Number of subjects: 120
Study 32485663 — intervention group
Group type: EXPERIMENTAL
Intervention: Thai dance exercise on soft surface
Number of subjects: 120
Study 32485663 — intervention group
Group type: COMPARATOR
Intervention: Thai dance exercise on hard surface
Number of subjects: 120
Study 35473650 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based telemental health group workshops (STEP-Home cognitive-behavioral group workshop)
Number of subjects: 74
Study 35473650 — intervention group
Group type: COMPARATOR
Intervention: Present-centered group therapy (TAU)
Number of subjects: 74
Study 35473650 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based telemental health delivery (VC)
Number of subjects: 74
Study 32197342 — intervention group
Group type: EXPERIMENTAL
Intervention: Five-day intensive holiday cooking program followed by six weeks of weekly meal kits with Facebook support groups
Number of subjects: 118
Study 32197342 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 118
Study 35239885 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated experiential learning of traditional Chinese and Western medicine
Number of subjects: 190
Study 35239885 — intervention group
Group type: COMPARATOR
Intervention: Regular health education
Number of subjects: 190
Study 32063629 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage manipulation (20 min/day for 6 days)
Number of subjects: 0
Study 32063629 — intervention group
Group type: COMPARATOR
Intervention: Low back muscle exercise (3 sessions/day for 15 days)
Number of subjects: 0
Study 34508839 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led intervention to prevent heart failure
Number of subjects: 334
Study 34508839 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 334
Study 34508839 — intervention group
Group type: EXPERIMENTAL
Intervention: Global longitudinal strain (GLS)
Number of subjects: 334
Study 34508839 — intervention group
Group type: EXPERIMENTAL
Intervention: Estimated glomerular filtration rate
Number of subjects: 334
Study 34508839 — intervention group
Group type: EXPERIMENTAL
Intervention: Charlson comorbidity score
Number of subjects: 334
Study 34508839 — intervention group
Group type: EXPERIMENTAL
Intervention: E/e' ratio
Number of subjects: 334
Study 34508839 — intervention group
Group type: EXPERIMENTAL
Intervention: GLS in patients on baseline angiotensin convertase enzyme inhibitors
Number of subjects: 334
Study 34508839 — intervention group
Group type: EXPERIMENTAL
Intervention: GLS in patients on baseline beta-blockers
Number of subjects: 334
Study 34508839 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical model based on age, gender, and Charlson score
Number of subjects: 334
Study 33749798 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic Acid (HA)
Number of subjects: 35
Study 33749798 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Control)
Number of subjects: 35
Study 32178813 — intervention group
Group type: EXPERIMENTAL
Intervention: Good Behavior Game (GBG) and MyTeachingPartner™ (MTP)
Number of subjects: 188
Study 32178813 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 188
Study 33739461 — intervention group
Group type: EXPERIMENTAL
Intervention: idelalisib and rituximab (IR)
Number of subjects: 149
Study 32940847 — intervention group
Group type: EXPERIMENTAL
Intervention: CEF (cyclophosphamide 75 mg/m2 orally for 14 days, epirubicin 60 mg/m2 and fluorouracil IV days one and eight for six cycles)
Number of subjects: 2104
Study 32940847 — intervention group
Group type: EXPERIMENTAL
Intervention: ddEC/T (dose-dense epirubicin 120 mg/m2 and cyclophosphamide IV every 2 weeks for six cycles with concurrent G-CSF then paclitaxel every 2 weeks for four cycles)
Number of subjects: 2104
Study 32940847 — intervention group
Group type: EXPERIMENTAL
Intervention: AC/T (doxorubicin 60 mg/m2 and cyclophosphamide 600 mg/m2 every 3 weeks for four cycles then four cycles q3 weekly paclitaxel 175 mg/m2)
Number of subjects: 2104
Study 35709551 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted neurological assessment educational program
Number of subjects: 55
Study 35709551 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 55
Study 32124925 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma FGF23 levels
Number of subjects: 5253
Study 32761316 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated pump-delivery device
Number of subjects: 105
Study 32761316 — intervention group
Group type: COMPARATOR
Intervention: Manual gravity-drip device
Number of subjects: 105
Study 33600287 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum after a nitrate-rich meal
Number of subjects: 20
Study 33600287 — intervention group
Group type: COMPARATOR
Intervention: No gum chewing (control)
Number of subjects: 20
Study 34034067 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ketamine (0.5-0.75 mg/kg) administered over 1-2 weeks, with four infusions.
Number of subjects: 68
Study 32152169 — intervention group
Group type: EXPERIMENTAL
Intervention: DeltaGold Tocotrienol 70%
Number of subjects: 0
Study 32152169 — intervention group
Group type: COMPARATOR
Intervention: 430 mg olive oil (placebo)
Number of subjects: 0
Study 35922522 — intervention group
Group type: EXPERIMENTAL
Intervention: Loading dose IV salbutamol (15 mcg/kg, max. 750 mcg)
Number of subjects: 58
Study 35922522 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 58
Study 35922522 — intervention group
Group type: EXPERIMENTAL
Intervention: Loading dose IV salbutamol
Number of subjects: 58
Study 34726262 — intervention group
Group type: EXPERIMENTAL
Intervention: Nemolizumab 60 mg every 4 weeks (Q4W) with concomitant topical treatments
Number of subjects: 303
Study 34726262 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 303
Study 33460045 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 1000
Study 33460045 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000
Study 34002319 — intervention group
Group type: EXPERIMENTAL
Intervention: WATCHMAN
Number of subjects: 51
Study 34002319 — intervention group
Group type: EXPERIMENTAL
Intervention: AMPLATZER Amulet
Number of subjects: 51
Study 34810349 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode Laser (DL)
Number of subjects: 98
Study 34810349 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin Gel (SG)
Number of subjects: 98
Study 36476355 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavender aromatherapy with mask oxygen after birth (n=48)
Number of subjects: 96
Study 36476355 — intervention group
Group type: COMPARATOR
Intervention: Carrier oil inhalation (Control group, n=48)
Number of subjects: 96
Study 36476355 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavender aromatherapy (n=48)
Number of subjects: 96
Study 33150798 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone (TIB) use
Number of subjects: 13110
Study 32673573 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical tube drain
Number of subjects: 90
Study 32673573 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiologic tape (KT) application
Number of subjects: 90
Study 32673573 — intervention group
Group type: COMPARATOR
Intervention: Routine surgical operation (Control)
Number of subjects: 90
Study 35140195 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban (10 mg per day from admission to discharge)
Number of subjects: 94
Study 35140195 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study 35140195 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 94
Study 34714194 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (5‐10 mg)
Number of subjects: 418
Study 34714194 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine gastrointestinal therapeutic system (GITS, 30‐60 mg)
Number of subjects: 418
Study 34714194 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment (both amlodipine and nifedipine)
Number of subjects: 418
Study 32948359 — intervention group
Group type: COMPARATOR
Intervention: 1-day LRD
Number of subjects: 135
Study 32948359 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day LRD
Number of subjects: 135
Study 35689457 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week, six-session web-based relapse prevention program
Number of subjects: 48
Study 35689457 — intervention group
Group type: COMPARATOR
Intervention: web-based self-monitoring only (control group)
Number of subjects: 48
Study 33618694 — intervention group
Group type: EXPERIMENTAL
Intervention: 2D ultrasound
Number of subjects: 1077
Study 33618694 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D ultrasound VOCAL technique
Number of subjects: 1077
Study 33618694 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomograms of 2D and 3D fetal thoracic measurements
Number of subjects: 1077
Study 33618694 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra- and inter-observer reliability assessment
Number of subjects: 1077
Study 32857027 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen-based bioinductive implant
Number of subjects: 30
Study 36213587 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck and face management in the observation group
Number of subjects: 60
Study 34022107 — intervention group
Group type: EXPERIMENTAL
Intervention: NAFLD/NASH tweets
Number of subjects: 193747
Study 34022107 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity tweets
Number of subjects: 193747
Study 32946451 — intervention group
Group type: EXPERIMENTAL
Intervention: Olyset LLIN
Number of subjects: 3393
Study 32946451 — intervention group
Group type: EXPERIMENTAL
Intervention: PermaNet 2.0 LLIN
Number of subjects: 3393
Study 32946451 — intervention group
Group type: EXPERIMENTAL
Intervention: NetProtect LLIN
Number of subjects: 3393
Study 32946451 — intervention group
Group type: COMPARATOR
Intervention: All LLIN products
Number of subjects: 3393
Study 35246403 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative flow ratio (QFR)
Number of subjects: 183
Study 35246403 — intervention group
Group type: COMPARATOR
Intervention: Fractional flow reserve derived from computed tomography (FFRCT)
Number of subjects: 183
Study 35246403 — intervention group
Group type: EXPERIMENTAL
Intervention: Lesion location in right coronary artery (RCA)
Number of subjects: 183
Study 34261489 — intervention group
Group type: EXPERIMENTAL
Intervention: Lettuce (100 g) with moderately high-fat meal
Number of subjects: 16
Study 34261489 — intervention group
Group type: EXPERIMENTAL
Intervention: Watercress (100 g) with moderately high-fat meal
Number of subjects: 16
Study 34261489 — intervention group
Group type: COMPARATOR
Intervention: Control meal (cellulose added)
Number of subjects: 16
Study 35075079 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow rhythm melody music (N=23)
Number of subjects: 46
Study 35075079 — intervention group
Group type: COMPARATOR
Intervention: No music (Control group, N=23)
Number of subjects: 46
Study 34726749 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescent intervention promoting knowledge and psychosocial outcomes, shared decisional support tool, and logistical strategies.
Number of subjects: 6967
Study 34726749 — intervention group
Group type: COMPARATOR
Intervention: Focus group data from intervention schools.
Number of subjects: 6967
Study 34627673 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid (TXA)
Number of subjects: 41
Study 34627673 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 34627673 — intervention group
Group type: EXPERIMENTAL
Intervention: Both TXA and Placebo
Number of subjects: 41
Study 34627673 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with pneumonia
Number of subjects: 41
Study 34301422 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency severity index clinical decision support tool (text banner on triage page)
Number of subjects: 384
Study 34301422 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 384
Study 34820818 — intervention group
Group type: EXPERIMENTAL
Intervention: web-based aftercare
Number of subjects: 142
Study 34820818 — intervention group
Group type: COMPARATOR
Intervention: analogue aftercare
Number of subjects: 142
Study 32830532 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine lactoferrin (BLF) supplementation
Number of subjects: 2200
Study 32830532 — intervention group
Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 2200
Study 32087750 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric screening care (G8 questionnaire and Timed Up and Go test)
Number of subjects: 320
Study 32087750 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (current usual care)
Number of subjects: 320
Study 32087750 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric screening care
Number of subjects: 320
Study 32087750 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 320
Study 35501401 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention aimed at prevention of GDM and postpartum diabetes
Number of subjects: 516
Study 35501401 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 516
Study 32242394 — intervention group
Group type: EXPERIMENTAL
Intervention: Xinfeng capsule (XFC)
Number of subjects: 255
Study 32242394 — intervention group
Group type: COMPARATOR
Intervention: Glucosamine (GS)
Number of subjects: 255
Study 616871171 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg atorvastatin once daily for 6 months
Number of subjects: 58
Study 616871171 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 58
Study 616871171 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 58
Study 35853580 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 week community exercise programme (CEP)
Number of subjects: 56
Study 34593024 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagenase injection
Number of subjects: 710
Study 34593024 — intervention group
Group type: COMPARATOR
Intervention: Limited fasciectomy surgery
Number of subjects: 710
Study 36279299 — intervention group
Group type: EXPERIMENTAL
Intervention: COACH intervention (integrated care management)
Number of subjects: 2365
Study 36279299 — intervention group
Group type: COMPARATOR
Intervention: eCAU (enhanced care-as-usual)
Number of subjects: 2365
Study 33829984 — intervention group
Group type: COMPARATOR
Intervention: High SFA/low MUFA Control oil (36.6% SFA/28.2% MUFA)
Number of subjects: 0
Study 33829984 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional canola oil (6.2% SFA/63.1% MUFA)
Number of subjects: 0
Study 33829984 — intervention group
Group type: EXPERIMENTAL
Intervention: High oleic acid canola oil (5.8% SFA/74.7% MUFA)
Number of subjects: 0
Study 36082521 — intervention group
Group type: EXPERIMENTAL
Intervention: TRS‐HFDM without NT‐ProBNP
Number of subjects: 5380
Study 36082521 — intervention group
Group type: EXPERIMENTAL
Intervention: TRS‐HFDM with NT‐ProBNP
Number of subjects: 5380
Study 33512117 — intervention group
Group type: EXPERIMENTAL
Intervention: Bulk-fill composite (Tetric N-Ceram Bulk fill) with universal adhesive (Tetric N-Bond Universal) in O cavity restorations
Number of subjects: 60
Study 33512117 — intervention group
Group type: EXPERIMENTAL
Intervention: Bulk-fill composite (Tetric N-Ceram Bulk fill) with universal adhesive (Tetric N-Bond Universal) in MO cavity restorations
Number of subjects: 60
Study 33512117 — intervention group
Group type: EXPERIMENTAL
Intervention: Bulk-fill composite (Tetric N-Ceram Bulk fill) with universal adhesive (Tetric N-Bond Universal) in MOD cavity restorations
Number of subjects: 60
Study 33512117 — intervention group
Group type: COMPARATOR
Intervention: Intact premolars (control group)
Number of subjects: 60
Study 33270032 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated texting platform for BP monitoring, 4-month program
Number of subjects: 201
Study 33270032 — intervention group
Group type: EXPERIMENTAL
Intervention: Perfect users (51/201), Adaptive users (66/201), Nonadaptive users (38/201) based on program conformity
Number of subjects: 201
Study 33270032 — intervention group
Group type: EXPERIMENTAL
Intervention: Enthusiast (17/155), Student (35/155), Minimalist (103/155) based on engagement style
Number of subjects: 201
Study 34258627 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat dairy diet (3.3 servings/d)
Number of subjects: 72
Study 34258627 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-fat dairy diet (3.3 servings/d)
Number of subjects: 72
Study 34258627 — intervention group
Group type: COMPARATOR
Intervention: Limited-dairy diet (≤3 servings/wk of nonfat milk)
Number of subjects: 72
Study 32193044 — intervention group
Group type: EXPERIMENTAL
Intervention: Etomidate plus fentanyl (group B)
Number of subjects: 70
Study 32193044 — intervention group
Group type: COMPARATOR
Intervention: Etomidate plus ketamine (group A)
Number of subjects: 70